Skip to main content

Table 1 (abstract P172). Post-COVID Symptoms in SAID Patients

From: Proceedings of the 28th European Paediatric Rheumatology Congress (PReS 2022)

Immunologic 33%

New PFAPA, recurrence of PFAPA, worsened flares, generalized lymphadenopathies and hepatosplenomegaly, Multisystem Inflammatory Syndrome in children (MIS-C)*, Multisystem Inflammatory Syndrome in adults (MIS-A) and Macrophage Activation Syndrome (MAS)^

Nervous system 29%

Headaches, hemiplegic migraine, increased seizures, weakness, cognitive issues, loss of taste, memory

Respiratory 29%

Cough, shortness of breath, worse asthma, chest pain

Constitutional 19%

Fatigue, inability to function

Musculoskeletal 10%

Arthralgias, myalgias

Cardiovascular 10%

Bradycardia, hypertension

Integumentary 10%

Rash, COVID toes

Miscellaneous 25%

Physician diagnosed Post-Acute Sequelae of SARS CoV-2 infection (PASC), prolonged recovery, chronic pharyngitis, chronic conjunctivitis, irritable bowel syndrome, kidney disease

  1. *MIS-C was reported in one patient whose SAID diagnosis was not specified and in one patient with a CAPS variant
  2. ^MIS-A and MAS were reported once by the same patient who had presumed COVID-19 infection and USAID at baseline
Back to article page

Pediatric Rheumatology

ISSN: 1546-0096